Renal Denervation for Resistant Hypertension—the Symplicity HTN-1 Study

The Lancet - United Kingdom
doi 10.1016/s0140-6736(14)60912-0
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

CONGRESS COVERAGE: Renal Sympathetic Denervation for Resistant Hypertension: Symplicity HTN-3 and the Power of Placebo

Open Hypertension Journal
Cardiovascular MedicineCardiology
2014English

Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

A Controlled Trial of Renal Denervation for Resistant Hypertension

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

Retrospective Morphometric Study of the Suitability of Renal Arteries for Renal Denervation According to the Symplicity HTN2 Trial Criteria

BMJ Open
Medicine
2016English

Renal Denervation in Patient With Resistant Hypertension: A Case Report

Srce i krvni sudovi
2012English

Joint UK Societies’ 2014 Consensus Statement on Renal Denervation for Resistant Hypertension

Heart
Cardiovascular MedicineCardiology
2014English

Renal Denervation in the Treatment of Resistant Hypertension: Results of a One-Year Observational Study

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2015English

Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Catheter-Based Renal Sympathetic Denervation – Long-Term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives

Interventional Cardiology Review
Cardiovascular MedicineCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy